Cytokinetics
CYTK
#2583
Rank
S$6.93 B
Marketcap
$58.59
Share price
-0.92%
Change (1 day)
-31.87%
Change (1 year)

Operating Margin for Cytokinetics (CYTK)

Operating Margin as of March 2025 (TTM): -3,191.11%

According to Cytokinetics 's latest financial reports and stock price the company's current Operating Margin is -3,191.11%. At the end of 2024 the company had an Operating Margin of -3,191.11%.

Operating Margin history for Cytokinetics from 2003 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-3,191.11%-54.34%
2023-6,988.63%1599.53%
2022-411.21%34.5%
2021-305.72%34.09%
2020-228.00%-49.66%
2019-452.93%34.23%
2018-337.41%-64.7%
2017-955.94%-6282.38%
201615.46%-111.82%
2015-130.86%319.39%
2014-31.20%-71.64%
2013-110.01%-79.4%
2012-534.07%-55.36%
2011-1,196.50%-37.66%
2010-1,919.40%-6437.74%
200930.29%-106.67%
2008-453.90%9.46%
2007-414.67%-78.86%
2006-1,961.56%291.67%
2005-500.82%80.98%
2004-276.73%-10.19%
2003-308.12%46.42%
2002-210.43%-3.14%
2001-217.25%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
1.50%-100.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,986.63%-6.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-84.50%-97.35%๐Ÿ‡บ๐Ÿ‡ธ USA
13.78%-100.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-27.36%-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.